Preclinical assessment of the feasibilit
โ
G. Eichenbaum; C. Pollock-Dove; J. Nguyen; S. Li; J. Evans; H. Borghys; L. Kenni
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 248 KB
๐ 1 views
In this paper, we present a preclinical approach for evaluating the feasibility of applying controlled-release (CR) oral drug delivery to increase the duration of exposure and lower the C max of compounds in a lead series of short half-life atypical antipsychotics. Three lead compounds in the series